N4 Partners ups stake in NeuroClin

NeuroClin is a neurological research organisation.

  • NeuroClin is backed by Foresight Group, Fullbrook Thorpe Investments and N4
  • N4 is an investment and advisory firm
  • The firm is based in Glasgow

N4 Partners (N4) has completed an additional investment into NeuroClin, a neurological research organisation.

NeuroClin is headquartered in Glasgow, Scotland. It is a global centre in Alzheimer’s vaccine research.

Backed by Foresight Group, Fullbrook Thorpe Investments and N4, NeuroClin launched its maiden Parkinson’s research programme and increased the headcount to around 60 employees, according to a release.

N4 is a Glasgow-based investment and advisory firm.